Mark Lingen to Risk Factors
This is a "connection" page, showing publications Mark Lingen has written about Risk Factors.
Connection Strength
0.334
-
A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer. J Dent Res. 2019 05; 98(5):489-497.
Score: 0.071
-
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013 Jan; 49(1):1-8.
Score: 0.045
-
Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India. Int J Cancer. 2026 Mar 15; 158(6):1517-1527.
Score: 0.028
-
Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan. Oral Oncol. 2025 Mar; 162:107210.
Score: 0.027
-
Inflammatory Tongue Conditions and Risk of Oral Tongue Cancer Among the US Elderly Individuals. J Clin Oncol. 2024 May 20; 42(15):1745-1753.
Score: 0.024
-
Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001 May; 13(3):176-82.
Score: 0.020
-
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000 Jul; 22(4):328-35.
Score: 0.019
-
Society of Behavioral Medicine position statement: Society of Behavioral Medicine supports oral cancer early detection by all healthcare providers. Transl Behav Med. 2019 07 16; 9(4):819-822.
Score: 0.018
-
Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897.
Score: 0.018
-
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 06; 125(6):650-669.
Score: 0.017
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.014
-
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41.
Score: 0.013
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex Dent J. 2012 May; 129(5):491-507.
Score: 0.011
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010 May; 141(5):509-20.
Score: 0.010